VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JXN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
JXNJackson Financial Inc.
$104.91$7.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksJXNFinancials

Jackson Financial Inc. (JXN) Financials

8Y historyFree accessUpdated daily

Underwriting profitability remains highly strained, with the 2026Q1 combined ratio of 113.8% highlighting the extreme sensitivity of GAAP margins to derivative valuation adjustments.

JXN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Revenue5.86B6.68B3.09B3.17B9.72B5.5B4.64B3.49B13.69B
Revenue Growth %-18.29%116.14%-2.31%-67.44%76.63%18.52%33.08%-74.51%-
Medical Costs & Claims-173M971M702M698M812M511M5.84B3.2B10.15B
Medical Cost Ratio %-2.95%14.53%22.7%22.05%8.35%9.29%125.82%91.6%74.14%
Gross Profit6.04B5.71B2.39B2.47B8.91B4.99B-1.2B293M3.54B
Gross Margin %102.95%85.47%77.3%77.95%91.65%90.71%-25.82%8.4%25.86%
Gross Profit Growth %-139%-3.12%-72.31%78.45%516.35%-509.22%-91.72%-
Operating Expenses6.53B5.83B1.37B1.51B1.17B647M1.29B1.1B1.15B
OpEx / Revenue %111.43%87.18%44.24%47.68%12.08%11.76%27.83%31.64%8.38%
Depreciation & Amortization0000011M10.8M11M10.8M
Combined Ratio %108.48%101.71%66.95%69.73%20.43%21.04%153.65%123.24%82.52%
Operating Income-497M-114M1.02B958M7.73B4.34B-2.49B-811M2.39B
Operating Margin %-8.48%-1.71%33.05%30.27%79.57%78.96%-53.65%-23.24%17.48%
Operating Income Growth %--111.15%6.68%-87.61%78%274.43%-207.15%-133.9%-
EBITDA-422M-14M1.12B1.07B7.83B4.36B-2.48B-800M2.4B
EBITDA Margin %-7.2%-0.21%36.32%33.71%80.58%79.16%-53.42%-22.93%17.56%
Interest Expense100M100M101M185M113M37M88M99M86.2M
Non-Operating Income-75M-100M-101M-109M-98M-37M-88M-99M-86.2M
Pretax Income-497M-114M1.02B958M7.73B4.34B-2.49B-811M2.39B
Pretax Margin %-8.48%-1.71%33.05%30.27%79.57%78.96%-53.65%-23.24%17.48%
Income Tax-167M-186M46M4M1.5B666M-854M-369M338.3M
Effective Tax Rate %33.6%163.16%4.5%0.42%19.46%15.33%34.28%45.5%14.14%
Net Income-373M27M946M934M6.19B3.42B-1.63B-497M1.99B
Net Margin %-6.36%0.4%30.6%29.51%63.64%62.09%-35.19%-14.24%14.51%
Net Income Growth %-393.7%-97.15%1.28%-84.9%81.04%309.12%-228.77%-125.03%-
EPS (Diluted)-5.35-0.2411.7410.7669.7535.89-17.29-5.2621.02
EPS Growth %-595.08%-102.04%9.11%-84.57%94.34%307.58%-228.71%-125.02%-
EPS (Basic)--0.2411.8610.9972.3435.89-17.29-5.2621.02
Diluted Shares Outstanding69.71M70.28M74.42M83.58M88.69M88.69M94.46M94.46M94.46M

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Variable Annuity Hedging Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Underwriting Profitability Remains Highly Volatile

As evidenced by the reported combined ratio of 113.8% in 2026Q1, Jackson Financial's underwriting profitability appears significantly strained, with historical data showing extreme fluctuations ranging from 3.2% to 140.5% over the last ten quarters, suggesting that GAAP-based margin analysis is heavily distorted by derivative mark-to-market accounting.

The wide variance in the combined ratio indicates that traditional insurance profitability metrics are insufficient for evaluating this business model. Investors should monitor the divergence between GAAP results and adjusted operating earnings, as the latter likely provides a more accurate view of the underlying fee-based revenue stability.

Revenue Growth Subject To Market

Based on the reported figures, revenue growth has exhibited extreme instability, with quarterly fluctuations ranging from a 178.4% increase in 2024Q2 to a 140.2% contraction in 2025Q2, reflecting the company's high sensitivity to equity market performance and the inherent volatility of its variable annuity fee-based revenue model.

The erratic top-line trajectory suggests that Jackson's revenue is less a function of traditional premium growth and more a reflection of asset-based fee income tied to separate account AUM. This dependency implies that sustained market downturns could lead to prolonged periods of revenue compression regardless of new business production.

Accounting Noise Masks Underlying Solvency

According to the provided financial statements, the company's net income has swung from a $795 million profit in 2024Q1 to a $424 million loss in 2026Q1, which warrants further investigation into whether these GAAP figures accurately represent the firm's true economic capital generation and long-term solvency.

The extreme volatility in net income appears to be driven by the accounting treatment of hedging instruments rather than operational failure. Analysts should prioritize statutory capital metrics over GAAP net income to determine if the company's risk management framework is effectively protecting its balance sheet during periods of market stress.

Operational Efficiency Obscured By Hedges

As reported in recent filings, the company's operating income has frequently diverged from revenue trends, with a notable $903 million operating profit in 2024Q1 followed by a $2 billion operating loss in 2023Q4, suggesting that fixed-cost absorption is secondary to the impact of derivative valuation adjustments.

The high fixed-cost base required to maintain the hedging infrastructure creates significant operating leverage that works against the company during periods of high market volatility. Investors should monitor whether the shift toward RILA products will eventually lead to a more stable and predictable operating margin profile over the long term.

JXN — Frequently Asked Questions

Quick answers to the most common questions about buying JXN stock.

What was Jackson Financial Inc.'s (JXN) revenue in 2025?

For fiscal year 2025, Jackson Financial Inc. (JXN) reported total revenue of $6.68B. This represents a 51.2% decline compared to $13.69B in 2018.

Is Jackson Financial Inc. (JXN) profitable?

Jackson Financial Inc. (JXN) is profitable, generating $27.0M in net income for the fiscal year ending 2025 with a net profit margin of 0.4%.

What is Jackson Financial Inc.'s operating profit margin?

Jackson Financial Inc. (JXN) reported an operating income of $-114.0M, resulting in an operating profit margin of -1.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Jackson Financial Inc.'s gross profit and gross margin?

Jackson Financial Inc. (JXN) generated $5.71B in gross profit for the year, representing a gross profit margin of 85.5%. This demonstrates the company's core pricing power and production efficiency.